| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20017201 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS20017202 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS20039910 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS20036459 | HPV | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44012280 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44027485 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44014592 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44006953 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44032797 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
| TVIS44027486 | HTLV-1 | ENSG00000154229.12 | protein_coding | PRKCA | No | No | 5578 | P17252 Q7Z727 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PRKCA |
|---|---|
| DrugBank ID | DB06641 |
| Drug Name | Perifosine |
| Target ID | BE0001132 |
| UniProt ID | P17252 |
| Regulation Type | |
| PubMed IDs | 16528479 |
| Citations | Knowling M, Blackstein M, Tozer R, Bramwell V, Dancey J, Dore N, Matthews S, Eisenhauer E: A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs. 2006 Sep;24(5):435-9. |
| Groups | Investigational |
| Direct Classification | Dialkyl phosphates |
| SMILES | CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL372764 |
